SPONSORED RESEARCH AGREEMENT
THIS AGREEMENT is made by and between CytoGenix, Inc. whose address is 9881 South Wilcrest,
Houston, Texas 77099 (hereinafter "SPONSOR") and Baylor College of Medicine, whose address is One
Baylor Plaza, Houston, Texas 77030 (hereinafter "BCM").
WHEREAS, SPONSOR desires that BCM perform certain technological research work using SPONSOR's
proprietary technology hereinafter defined, and
WHEREAS, SPONSOR is willing to advance funds to sponsor such Research, and
WHEREAS, SPONSOR desires to establish ownership of rights to intellectual property and technology which
may be developed during the course of such work, and
WHEREAS, BCM is willing to perform such Research.
NOW, THEREFORE, in consideration of the mutual covenants and promises herein contained, BCM and
SPONSOR agree as follows.
I. EFFECTIVE DATE
This Agreement shall be effective as of March 1, 2000.
II RESEARCH PROGRAM
2.1 BCM will use its best efforts to conduct the Research Program described in the attached Schedule A,
"Statement of Work," utilizing SPONSOR's proprietary technology as described in Schedule C and in
accordance with the "Budget" set forth in Schedule B, and will furnish the facilities necessary to carry out such
Research Program. The Research Program will be under the direction of Bert W. O'Malley, M.D.,
(O'MALLEY) Professor and Chairman, Department of Molecular and Cellular Biology, acting as Principal
2.2 The Research Program shall be performed during the period from
Page 1 of 17
March 1, 2000 to March 31, 2002. SPONSOR shall have the option of extending the Research Program under
mutually agreeable support terms.
2.3 SPONSOR understands that O'MALLEY's primary mission is Professor and Chairman, consequently, the
Research Program will be performed in a manner consistent with that mission. Specifically, the manner of
performance of the Research Program shall be determined by mutual agreement between O'MALLEY, as the
representative of BCM, and S